📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cost-Effectiveness Of Once-Daily Single-Inhaler Triple Therapy In COPD: The IMPACT Trial. (2019)

First Author: Ismaila AS

Attributed to: Alpha-1-antitrypsin (AT) deficiency and the serpinopathies: pathobiology and new therapeutic strategies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2147/copd.s216072

PubMed Identifier: 31819401

Publication URI: http://europepmc.org/abstract/MED/31819401

Type: Journal Article/Review

Volume: 14

Parent Publication: International journal of chronic obstructive pulmonary disease

ISSN: 1176-9106